| IV-069 Laura Villain Considerations for the application of PBPK to optimize drug therapies in special populations: The Open Systems Pharmacology solutions Thursday 15:00-16:30 |
| IV-069 Laura Villain Considerations for the application of PBPK to optimize drug therapies in special populations: The Open Systems Pharmacology solutions Thursday 15:00-16:30 |